Vitiligo

Descriptive text is not available for this image BASICS

DESCRIPTION

  • An acquired depigmentation of the epidermis due to a loss of melanocytes. There are two major clinical variants.
  • Nonsegmental vitiligo: Represents 80–90% of cases, is often bilateral, symmetrical and enlarges over time (1); subtypes include: the following
    • Acrofacial: on face and distal extremities (“lip-tip” pattern)
    • Generalized: progressive, with flares, commonly associated with autoimmunity; common locations are acral, periorificial, and in sites sensitive to pressure/friction (Koebner phenomenon).
    • Mixed: coexistence of nonsegmental and segmental
    • Mucosal (multifocal): only mucosal surfaces
    • Universal: involves >80% of the body surface area; most likely to have family history; comorbidities are common and associated with poorest quality-of-life (QOL).
  • Segmental vitiligo: typically unilateral distribution and earlier onset than nonsegmental (face > trunk > extremities). Lesions may present within a dermatome (i.e., trigeminal), follow Blaschko lines, and involve melanocytes of hair follicles causing leukotrichia. These lesions are less responsive to treatment. Subtypes include:
    • Bisegmental: bilaterally distributed
    • Plurisegmental: multiple segments
    • Unisegmental: single segment
  • Undetermined/unclassified:
    • Focal: few lesions, random distribution; may be able to later classify as on one of the forms above after 1 to 2 years
    • Mucosal (focal type): only mucosal surfaces

EPIDEMIOLOGY

  • 50% begin before age 20 years; females in 1st decade; males in 5th decade; onset earlier with positive family history
  • Predominance: male = female; however, females are more likely to seek treatment.

Prevalence

Approximately 0.5–2% the world; except in Africa and India where prevalence can be almost 10% in certain regions

ETIOLOGY AND PATHOPHYSIOLOGY

Likely a spectrum of disorders with a common phenotype and multiple mechanisms contribute to the pathology.

  • Autoimmune: humoral autoantibodies and skin-homing T cells
  • Neural: dysregulation of nerve endings leading to decreased melanin production/increased destruction
  • Oxidative stress: Exogenous and endogenous stressors increase reactive oxygen species like hydrogen peroxide.

Genetics

  • Polygenic/multifactorial inheritance
  • 20% of patients report affected relative; however, monozygotic twins have only 23% concordance.

RISK FACTORS

  • Family history: vitiligo/autoimmune disorders
  • Personal history: associated conditions

COMMONLY ASSOCIATED CONDITIONS

Common comorbidities include (2):

  • Autoimmune and connective tissue diseases: systemic sclerosis, alopecia areata, discoid lupus erythematous, Sjögren syndrome, myasthenia gravis, systemic lupus erythematous, rheumatoid arthritis, pernicious anemia
  • Endocrine: thyroid disease (hypothyroidism/hyperthyroidism), hypoparathyroidism, Addison disease, insulin-dependent diabetes, metabolic syndrome
  • Allergic and dermatologic: psoriasis, atopic dermatitis, lichen planus, chronic urticaria, allergic rhinitis, asthma
  • Psychiatric: body dysmorphic disorder, adjustment disorder, impulse control disorder, developmental disorder, suicide and intentional self-inflicted injury, attention deficit hyperactive disorder
  • Sensorineural hearing hypoacusis and ophthalmic abnormalities

Pediatric Considerations
Association with Hashimoto thyroiditis; screening at onset and possibly annually may be beneficial.

Descriptive text is not available for this image DIAGNOSIS

HISTORY

  • Inquire about recent history of sunburns, pregnancy, skin trauma, or emotional stress.
  • Discuss family history of premature graying, vitiligo, and autoimmune disorders.
  • Complete a review of systems for related associated conditions.
  • Ascertain psychological impact on QOL, Dermatology Life Quality Index.

PHYSICAL EXAM

  • Complete a full-body skin exam with Wood lamp (depigmentation appears bright blue-white)
  • Lesions are rounded well-demarcated, uniform, white macules and nonscaly patches.

DIFFERENTIAL DIAGNOSIS

  • Infectious: tinea versicolor, leprosy, leishmaniasis, onchocerciasis, treponematoses
  • Postinflammatory hypopigmentation: psoriasis, atopic dermatitis, pityriasis alba, systemic lupus erythematosus, scleroderma
  • Inherited hypomelanosis: piebaldism, tuberous sclerosis, Waardenburg syndrome, hypomelanosis of Ito, Vogt-Koyanagi-Harada disease
  • Malformations: nevus anemicus, nevus depigmentosus
  • Paraneoplastic: hypopigmented mycosis fungoides, melanoma-associated leukoderma
  • Occupational/chemical/drug induced leukoderma
  • Melasma: Normal skin may be confused as vitiligo in the setting of surrounding hyperpigmentation.
  • Halo nevi
  • Lichen sclerosus
  • Idiopathic guttate hypomelanosis
  • Progressive macular hypomelanosis

DIAGNOSTIC TESTS & INTERPRETATION

Initial Tests (lab, imaging)

Obtain thyroid labs and consider other autoimmune labs based on history.

Diagnostic Procedures/Other

  • Skin biopsy is rarely needed.
  • Consider ophthalmologic and audiologic evaluations.

There's more to see -- the rest of this topic is available only to subscribers.